RETINALGENIX DNA/RNA GPS Trademark
Trademark Overview
On Thursday, October 19, 2023, a trademark application was filed for RETINALGENIX DNA/RNA GPS with the United States Patent and Trademark Office. The USPTO has given the RETINALGENIX DNA/RNA GPS trademark a serial number of 98230742. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, December 3, 2024. This trademark is owned by Retinalgenix Technologies Inc.. The RETINALGENIX DNA/RNA GPS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Lacrimal, nasal and buccal test kits composed primarily of swabs and diagnostic reagents for medical use; Blood testing kits composed primarily of diagnostic test strips and reagents for blood analysis for medical purposes
Laboratory services for lacrimal, nasal, buccal, and blood testing for medical analysis services for diagnostic and treatment purposes
General Information
| Serial Number | 98230742 |
| Word Mark | RETINALGENIX DNA/RNA GPS |
| Filing Date | Thursday, October 19, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Tuesday, December 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Lacrimal, nasal and buccal test kits composed primarily of swabs and diagnostic reagents for medical use; Blood testing kits composed primarily of diagnostic test strips and reagents for blood analysis for medical purposes |
| Pseudo Mark | RETINAL GENIX DNA RNA GPS |
| Goods and Services | Laboratory services for lacrimal, nasal, buccal, and blood testing for medical analysis services for diagnostic and treatment purposes |
| NOT AVAILABLE | DNA/RNA |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 2, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Retinalgenix Technologies Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Petaluma, CA 94954 |
Trademark Events
| Event Date | Event Description |
| Monday, October 23, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 15, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 31, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 31, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, December 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 3, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, December 3, 2024 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 3, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 3, 2024 | SUSPENSION LETTER WRITTEN |
| Tuesday, December 3, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 31, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
